首页> 外文OA文献 >Collagen and Elastin based Tissue Engineered Vascular Grafts
【2h】

Collagen and Elastin based Tissue Engineered Vascular Grafts

机译:基于胶原蛋白和弹性蛋白的组织工程血管移植物

摘要

Cardiovascular disease is the leading cause of death worldwide, accounting for 29% of all global deaths and is set to rise to 23 million deaths a year by 2030 (World Health Organisation, 2012). Arterial bypassing, both peripheral and coronary, is usually performed with autologously harvested vessels. However, the quantity available is often very limited as well as the vessels of elderly patients often suffering from thrombus, aneurysm formation or arthrosclerosis in high pressure arterial sites. The shortcomings of autografts has led to a substantial amount of research being directed towards tissue engineered vascular grafts (TEVGs) (Kakisis et al., 2005). Currently available artificial grafts for small diameter vasculature (mm) suffer from poor patency rates due to thrombosis, aneurysm formation, and a compliance mismatch, which often stems from the inherent properties of synthetic polymers.The primary goal of the research presented in this thesis was to develop a small diameter tissue engineered vascular graft (TEVG) using the natural polymers collagen and elastin, coupled with dynamic mechanical conditioning. In this context, the aim was to develop a collagen-elastin composite scaffold with optimised intrinsic physiochemical characteristics which displayed the capacity to support smooth muscle cells in vitro while also displaying suitable viscoelastic properties. Subsequent investigation focused on emulating the anatomical architecture of native vessels using this novel collagen-elastin composite, and examining in vitro maturation through dynamic conditioning in a custom designed pulsatile bioreactor.In the study presented in Chapter 2 of this thesis, elastin addition to a porous collagen scaffold was shown to play a major role in altering its biological and mechanical response. The addition of elastin improved the viscoelastic characteristics with a higher degree of cyclical strain recovery and creep resistance, which indicates the biomaterial may possess sufficient recoil to be utilised for long-term cyclical distension with reduced aneurysm risk. Additionally, the gene expression and proliferation data suggested that the presence of elastin resulted in a more contractile smooth muscle cell (SMC) phenotype, in the absence of any exogenous stimulation. This biomaterial platform was deemed to possess great potential for cardiovascular tissue engineering and was amenable to multiple fabrication methods.In Chapter 3, this biomimetic collagen-elastin composite was subsequently fabricated into a physiologically relevant bilayered tubular architecture. The bilayered scaffold consisted of a porous outer layer with an optimised microarchitecture to support SMCs, while the inner layer consisted of a dense film designed to increase the overall scaffold mechanical properties and present a suitable surface for future endothelial seeding. The properties of the dense luminal lining were shown to be highly controllable via crosslinking, which enabled the modification of the mechanical properties, degradation resistance, and inflammatory profile. These bilayered tubular scaffolds were ultimately considered highly suitable for further investigation as a TEVG.In Chapter 4, a novel pulsatile flow bioreactor system was developed which was capable of recreating the complex haemodynamic environment in vitro. The system was capable of applying physiological fluid shear stresses, cyclical strain and pulsatile pressure to mounted constructs. The flexible design allowed the mounting of variable diameter constructs and was designed to be utilised to examine the effect of mechanical stimulation on the in vitro maturation of the bilayered tubular collagen-elastin TEVGs described. In the final chapter (Chapter 5), the effect of TEVG architecture, crosslinking, and dynamic conditioning on the maturation of the grafts was examined in the custom pulsatile bioreactor from Chapter 4. Specifically, bilayered scaffolds coupled with EDAC crosslinking displayed far greater mechanical properties than single layered scaffolds and DHT crosslinking respectively. Furthermore, the application of dynamic conditioning resulted in further increases in the TEVG mechanical properties as a result of increased cell density, improved collagen circumferential alignment, and an apparent increase in vessel wall density.Collectively, this study has led to the development of a composite bilayered tubular scaffold with optimised intrinsic physiochemical characteristics to support smooth muscle cells in vitro while subsequently displaying suitable viscoelastic properties for sustained dynamic conditioning in a custom designed pulsatile bioreactor.
机译:心血管疾病是全球主要的死亡原因,占全球所有死亡的29%,并且到2030年,每年将有2300万人死亡(世界卫生组织,2012)。通常使用自体收集的血管进行外周和冠状动脉旁路手术。但是,可用的数量通常非常有限,并且老年患者的血管经常在高压动脉部位遭受血栓,动脉瘤形成或动脉硬化。自体移植的缺点导致大量研究针对组织工程血管移植(TEVG)(Kakisis等,2005)。由于血栓形成,动脉瘤形成和顺应性不匹配,目前可用的用于小直径脉管系统(mm)的人工移植物的通畅率很低,这通常源于合成聚合物的固有特性。本文提出的研究的主要目标是利用天然聚合物胶原蛋白和弹性蛋白,结合动态机械条件,开发出小直径的组织工程化血管移植物(TEVG)。在此背景下,目的是开发具有优化的内在物理化学特征的胶原蛋白-弹性蛋白复合支架,该支架表现出在体外支持平滑肌细胞的能力,同时还表现出合适的粘弹性。随后的研究重点是使用这种新型胶原蛋白-弹性蛋白复合物模拟天然血管的解剖结构,并在定制的搏动性生物反应器中通过动态条件检查体外成熟。在本论文第二章中提出的研究中,弹性蛋白除多孔胶原蛋白支架被证明在改变其生物学和机械反应中起主要作用。弹性蛋白的添加改善了粘弹性特性,具有更高程度的周期性应变恢复和抗蠕变性,这表明该生物材料可能具有足够的后坐力,可用于长期周期性膨胀,从而降低了动脉瘤的风险。另外,基因表达和增殖数据表明,在没有任何外源刺激的情况下,弹性蛋白的存在导致更收缩的平滑肌细胞(SMC)表型。该生物材料平台被认为具有心血管组织工程的巨大潜力,并适用于多种制造方法。在第三章中,该仿生胶原蛋白-弹性蛋白复合物随后被制造为具有生理意义的双层管状结构。双层支架由具有优化的微结构的多孔外层组成,以支持SMC,而内层由致密膜组成,该致密膜旨在增加支架的总体机械性能并提供适合将来内皮接种的表面。通过交联,致密的内腔衬里的性能显示出高度可控的特性,从而可以改善机械性能,抗降解性和发炎性。这些双层管状支架最终被认为非常适合作为TEVG进行进一步研究。在第4章中,开发了一种新型的脉动生物反应器系统,该系统能够在体外重建复杂的血液动力学环境。该系统能够将生理流体的切应力,周期性应变和脉动压力施加到安装好的结构上。灵活的设计允许安装可变直径的结构,并被设计用来检查机械刺激对双层管状胶原蛋白-弹性蛋白TEVG体外成熟的影响。在最后一章(第5章)中,在第4章的定制脉动生物反应器中研究了TEVG结构,交联和动态调节对移植物成熟的影响。特别是,双层支架与EDAC交联表现出更大的机械性能分别比单层支架和DHT交联。此外,动态调节的应用由于细胞密度增加,胶原蛋白周向排列改善以及血管壁密度明显增加而导致TEVG力学性能进一步提高。总的来说,这项研究导致了复合材料的发展具有优化的固有物理化学特性的双层管状支架,可在体外支持平滑肌细胞,并随后在定制的搏动生物反应器中显示出合适的粘弹性质,以进行持续的动态调节。

著录项

  • 作者

    Ryan Alan J;

  • 作者单位
  • 年度 2016
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号